These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 22724663

  • 1. Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview.
    Angeli F, Reboldi G, Mazzotta G, Poltronieri C, Verdecchia P.
    Expert Opin Drug Saf; 2012 Jul; 11(4):659-70. PubMed ID: 22724663
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aliskiren: an oral direct renin inhibitor for the treatment of hypertension.
    Sanoski CA.
    Pharmacotherapy; 2009 Feb; 29(2):193-212. PubMed ID: 19170589
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term safety, tolerability, and antihypertensive efficacy of aliskiren, an oral direct renin inhibitor, in Japanese patients with hypertension.
    Kushiro T, Itakura H, Abo Y, Gotou H, Terao S, Keefe DL.
    Hypertens Res; 2009 Mar; 32(3):169-75. PubMed ID: 19262478
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
    Uresin Y, Taylor AA, Kilo C, Tschöpe D, Santonastaso M, Ibram G, Fang H, Satlin A.
    J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):190-8. PubMed ID: 18205098
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL, Schmieder RE, Azizi M, Aldigier JC, Januszewicz A, Zidek W, Chiang Y, Satlin A.
    Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
    [Abstract] [Full Text] [Related]

  • 11. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K.
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of the dose--response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension.
    Puig JG, Schunkert H, Taylor AA, Boye S, Jin J, Keefe DL.
    Clin Ther; 2009 Dec; 31(12):2839-50. PubMed ID: 20110023
    [Abstract] [Full Text] [Related]

  • 14. Cardio-renal protection with aliskiren, a direct renin inhibitor, in the ASPIRE HIGHER program.
    Lee HY, Oh BH.
    Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):251-7. PubMed ID: 19296761
    [Abstract] [Full Text] [Related]

  • 15. Aliskiren: the first direct renin inhibitor available for clinical use.
    Morganti A, Lonati C.
    J Nephrol; 2011 Mar; 24(5):541-9. PubMed ID: 21786226
    [Abstract] [Full Text] [Related]

  • 16. Aliskiren in the management of hypertension.
    Barrios V, Escobar C.
    Am J Cardiovasc Drugs; 2010 Mar; 10(6):349-58. PubMed ID: 21090828
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Direct renin inhibition: focus on aliskiren.
    Pool JL.
    J Manag Care Pharm; 2007 Oct; 13(8 Suppl B):21-33. PubMed ID: 17970614
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.